JP2013511530A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511530A5
JP2013511530A5 JP2012540005A JP2012540005A JP2013511530A5 JP 2013511530 A5 JP2013511530 A5 JP 2013511530A5 JP 2012540005 A JP2012540005 A JP 2012540005A JP 2012540005 A JP2012540005 A JP 2012540005A JP 2013511530 A5 JP2013511530 A5 JP 2013511530A5
Authority
JP
Japan
Prior art keywords
group
amino acid
acid selected
mixture
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012540005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511530A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/057053 external-priority patent/WO2011063003A2/en
Publication of JP2013511530A publication Critical patent/JP2013511530A/ja
Publication of JP2013511530A5 publication Critical patent/JP2013511530A5/ja
Pending legal-status Critical Current

Links

JP2012540005A 2009-11-17 2010-11-17 ライム病抗体の検出のためのペプチドおよび方法 Pending JP2013511530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26209909P 2009-11-17 2009-11-17
US61/262,099 2009-11-17
PCT/US2010/057053 WO2011063003A2 (en) 2009-11-17 2010-11-17 Peptides and methods for the detection of lyme disease antibodies

Publications (2)

Publication Number Publication Date
JP2013511530A JP2013511530A (ja) 2013-04-04
JP2013511530A5 true JP2013511530A5 (enExample) 2013-12-26

Family

ID=44060312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540005A Pending JP2013511530A (ja) 2009-11-17 2010-11-17 ライム病抗体の検出のためのペプチドおよび方法

Country Status (8)

Country Link
US (1) US8568989B2 (enExample)
EP (1) EP2501719B1 (enExample)
JP (1) JP2013511530A (enExample)
KR (1) KR20120096932A (enExample)
CN (1) CN102791727A (enExample)
AU (1) AU2010322085B2 (enExample)
CA (1) CA2781110C (enExample)
WO (1) WO2011063003A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
DK3489685T3 (da) 2011-11-21 2023-12-04 Zoetis Services Llc Signalforstærkning i sidestrømning og tilsvarende immunoassays
JP2013164414A (ja) * 2012-01-13 2013-08-22 Nippon Meat Packers Inc 抗菌ペプチドを用いた微生物の検出方法及び検出用キット
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US20150293086A1 (en) * 2014-04-14 2015-10-15 Abreos Biosciences, Inc. Lateral flow immunoassay
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US11061028B2 (en) * 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
CN104330555B (zh) * 2014-10-22 2016-05-11 中国检验检疫科学研究院 检测伯氏疏螺旋体抗体的试纸、试纸制备方法及试剂盒
EP4465021A3 (en) 2015-08-04 2025-02-26 Zoetis Services LLC Signal amplification in solution-based plasmonic specific-binding partner assays
WO2017035389A1 (en) * 2015-08-27 2017-03-02 Quidel Corporation Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
CN105548577B (zh) * 2016-02-04 2017-09-19 安徽医科大学 一种琥珀酰‑β‑环糊精修饰的莱姆病检测用蛋白质芯片及其制备与应用
EP3252470B1 (en) * 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample
USD800912S1 (en) 2016-06-17 2017-10-24 Abreos Biosciences, Inc. Point-of-care diagnostic device
WO2018031887A1 (en) 2016-08-12 2018-02-15 Abreos Biosciences, Inc. Detection and quantification of natalizumab
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
KR102486615B1 (ko) 2017-01-30 2023-01-11 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
JP7062803B1 (ja) * 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
EP4220166A1 (en) 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) In vitro method for detecting antibodies in a sample
EP4511656A1 (en) * 2022-04-04 2025-02-26 Antigen Discovery Inc. Antigens for detection of early lyme disease

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5385826A (en) 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
DE4015911A1 (de) 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5187065A (en) 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
SG122738A1 (en) 1990-06-15 2006-06-29 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
US5155022A (en) 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5324630A (en) 1991-06-28 1994-06-28 The Regents Of The University Of California Methods and compositions for diagnosing lyme disease
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
WO1993003184A1 (en) 1991-08-09 1993-02-18 Mccann Associates, Inc. Method for detecting lyme disease and composition
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5308753A (en) 1992-02-20 1994-05-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for purifying and detecting IGM antibodies
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
EP0894143B2 (en) 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6902893B1 (en) 1997-06-20 2005-06-07 Gil H. Choi Lyme disease vaccines
ES2270523T3 (es) 1997-06-30 2007-04-01 The Administrators Of The Tulane Educational Fund Antigenos de superficie y proteinas utiles en composiciones para la diagnosis y prevencion de la enfermedad de lyme.
US6667038B1 (en) 1999-04-21 2003-12-23 Boston Medical Center Corp. Prevention, diagnosis and treatment of lyme disease
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
US6665652B1 (en) 1999-07-28 2003-12-16 Richard B. Porwancher Method of diagnosis of lyme disease
CA2446246A1 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US6838247B2 (en) 2002-06-19 2005-01-04 Bowen Research And Training Test for lyme disease
EP2292762A3 (en) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System VMP-like sequences of pathogenic Borrelia species and strains
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7390626B2 (en) * 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
US8232045B2 (en) 2005-03-29 2012-07-31 Inverness Medical Switzerland Gmbh Colloidal metal conjugates
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US8399261B2 (en) 2007-06-27 2013-03-19 Inbios International, Inc. Lateral flow assay system and methods for its use
EP2058663A1 (en) 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
JP2009236685A (ja) 2008-03-27 2009-10-15 Sysmex Corp クロマトグラフィー用試験具

Similar Documents

Publication Publication Date Title
JP2013511530A5 (enExample)
JP2015504420A5 (enExample)
FI3502125T3 (fi) Peptidejä ja menetelmiä lymen taudin vasta-aineiden havaitsemiseksi
JP2013511546A5 (enExample)
AU2007325465B2 (en) Assay membrane and method of use thereof
JP2016500815A5 (enExample)
CN101918445B (zh) 用于早期妊娠诊断的组合物和方法
JP5855094B2 (ja) 腎疾患のためのマーカー
US20250122262A1 (en) Diagnostic, prognostic, therapeutic and screening protocols
JP2017505436A5 (enExample)
EP2362944A2 (en) Methods and products for measuring free immunoglobulin light chain molecules
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
RU2019113127A (ru) REP белок в качестве белкового антигена для диагностических анализов
CN101918432B (zh) 与类风湿性关节炎自身抗体发生免疫反应的合成肽
JP2007510165A (ja) 結合アッセイ成分
US7094551B2 (en) Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
EP4074725A2 (en) Switching binder, preparation method therefor, and pharmaceutical composition, assay kit, and antigen and antibody assay method, each using same
TWI860470B (zh) 肺炎黴漿菌之免疫測定方法及免疫測定器具
KR102397684B1 (ko) 항체의 항원 결합 부위에 결합하는 펩티드 및 이를 이용한 분석 방법
JP2008521824A (ja) 生理活性インタクト副甲状腺ホルモン(pth)1−84に対する選択的結合特異性を有する抗体および同抗体を作製するためのペプチド抗原
JP6329127B2 (ja) 細胞フィブロネクチンについての迅速な検査
JP4961577B2 (ja) アレルギーを診断するエピトープポリペプチド
RU2439080C2 (ru) Биоанализ и пептиды, используемые в нем
CN103235136B (zh) 蛋白质类药物三维构像的抗体阵序列检测方法
Class et al. Patent application title: Diagnostic, prognostic, therapeutic and screening protocols Inventors: David Andrew Anderson (Melbourne, AU) Mary Louise Garcia (Melbourne, AU) Nadine Carmel Barnes (Melbourne, AU) Khayriyyah Mohd Hanafiah (Melbourne, AU) Alan Lee Landay (Melbourne, AU)